NEWS CENTER

Keyuan Pharmaceutical holds a marketing special meeting titled "Sprint for the Fourth Quarter," comprehensively outlining the closing-phase strategy.

Publish Time:

2025-10-09

From October 7 to 8, Shandong Keyuan Pharmaceutical Co., Ltd. (stock code: 301281.SZ) held a grand marketing-focused work conference. The meeting was themed "Charge Full Speed into the Fourth Quarter—Win the Closing Battle!" and featured a comprehensive review of the company's performance from January to September, along with strategic planning for the fourth quarter and beyond, ensuring the successful achievement of this year's business objectives. Chairman and President Gao Chunpo, Executive Vice President Ren Guangqiang, heads of various departmental centers, plant directors, and all members of the Marketing Center attended the event.

The meeting kicked off with the solemn rendition of "The Anthem of Linuo." Heads of various departments, regional command centers, and branch companies successively reported on their sales performance from January to September, as well as their upcoming work plans. They engaged in in-depth analysis and discussions on market trends, pricing strategies, and customer relationship management, ultimately reaching several key resolutions and outlining specific action plans. These decisions spanned multiple dimensions, including product development, production processes, marketing initiatives, pricing strategies, and international collaborations.

The meeting emphasized that the fourth quarter is a critical phase for achieving the year-end goals and tasks, urging all marketing personnel to stay focused on targets, take full responsibility, and make every effort to accelerate progress. Additionally, the meeting organized specialized marketing training, quality and regulatory compliance workshops, as well as updates on the progress of new product launches, further enhancing the team’s professional capabilities and ensuring adherence to industry standards.

The successful convening of this marketing special meeting has unified thinking and clarified the roadmap for Keyuan Pharmaceutical as it makes a full-fledged sprint toward the fourth quarter and secures its year-end goals. Amidst the profound transformations and intense competition in the pharmaceutical industry, Keyuan Pharmaceutical is advancing with a clear strategic vision and unwavering execution—deepening product potential, strengthening its new-product pipeline, and optimizing its global marketing network. These efforts are steadily enhancing the company’s core competitiveness, laying a solid foundation for a diversified and mutually beneficial growth strategy, and enabling Keyuan Pharmaceutical to continue contributing meaningfully to the creation of a healthier future.

Publicly Available Information: Environmental Impact Assessment Report (Draft for Comments) on the Intelligent Pilot-Scale Platform Project for Specialized, Fine, and Novel Active Pharmaceutical Ingredients at Shandong Keyuan Pharmaceutical Co., Ltd.

Keyuan Pharmaceutical's LiNuo Pharmaceutical Injection AI + Computing Power Intelligent Factory has been officially completed, showcasing seven major highlights that underscore its cutting-edge strength!